Neoadjuvant treatment with trastuzumab in HER2-positive breast cancer: results from the GeparQuattro study (Q43121691)

From Wikidata
Jump to navigation Jump to search
scientific article published on 22 March 2010
edit
Language Label Description Also known as
English
Neoadjuvant treatment with trastuzumab in HER2-positive breast cancer: results from the GeparQuattro study
scientific article published on 22 March 2010

    Statements

    Neoadjuvant treatment with trastuzumab in HER2-positive breast cancer: results from the GeparQuattro study (English)
    Mahdi Rezai
    Jens Huober
    Hans Tesch
    Ingo Bauerfeind
    Jörn Hilfrich
    Holger Eidtmann
    Bernd Gerber
    Claus Hanusch
    Thorsten Kühn
    Andreas du Bois
    Jens-Uwe Blohmer
    Christoph Thomssen
    Serban Dan Costa
    Christian Jackisch
    Manfred Kaufmann
    Keyur Mehta
    Gunter von Minckwitz
    22 March 2010
    2024-2031

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit